St Bartholomew's Hospital-Centre for Experimental Cancer Medicine (Site 2105)

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Hodgkin lymphoma

Closed trials

• Completed

  A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Physician's Choice Chemotherapy in PD-(L)1-refractory, Relapsed or Refractory Classical Hodgkin Lymphoma (MK-4280A-008)

  NCT05508867· Phase 2· Merck Sharp & Dohme LLC· Source